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Abstract 
Interest in using ultrasound energy in wound management and intracellular drug 
delivery has been growing rapidly.  Development and treatment optimization of such 
non-diagnostic applications requires a fundamental understanding of interactions between 
the acoustic wave and phospholipid membranes, be they cell membranes or liposome 
bilayers. This work investigates the changes in membrane permeation (leakage 
mimicking drug release) in vitro during exposure to ultrasound applied in two frequency 
ranges: “conventional” (1 MHz and 1.6 MHz) therapeutic ultrasound range and low (20 
kHz) frequency range.  Phospholipids vesicles were used as controllable biological 
membrane models. The membrane properties were modified by changes in vesicle 
dimensions and incorporation of poly(ethylene glycol) i.e. PEGylated lipids.  Egg 
phosphatidylcholine vesicles with 5 mol % PEG were prepared with sizes ranging from 
100 nm to 1 μm.  Leakage was quantified in terms of temporal fluorescence intensity 
changes observed during carefully controlled ultrasound ON/OFF time intervals.  
Custom-built transducers operating at frequencies of 1.6 MHz (focused) and 1.0 MHz 
(unfocused) were used, the Ispta of which were 46.9 W/cm2 and 3.0 W/cm2, respectively. 
A commercial 20 kHz, point-source, continuous wave transducer with an Ispta of 0.13 
W/cm2 was also used for comparative purposes.  Whereas complete leakage was obtained 
for all vesicle sizes at 20 kHz, no leakage was observed for vesicles smaller than 100 nm 
in diameter at 1.6 or 1.0 MHz.   However, introducing leakage at the higher frequencies 
became feasible when larger (greater than 300 nm) vesicles were used, and the extent of 
leakage correlated well with vesicle sizes between 100 nm and 1 µm.  This observation 
suggests that physico-chemical membrane properties play a crucial role in ultrasound 
mediated membrane permeation and that low frequency (tens of kilohertz) ultrasound 
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exposure is more effective in introducing permeability change than the “conventional” (1 
MHz) therapeutic one. The experimental data also indicate that the leakage level is 
controlled by the exposure time.  The results of this work might be helpful to optimize 
acoustic field and membrane parameters for gene or drug delivery.  The outcome of this 
work might also be useful in wound management. 
PACS code: 43.35, 87.51 
Keywords: ultrasound exposure, therapeutic ultrasound, membrane permeability, giant 
vesicles, PEG2000
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1. Introduction 
Research interests in biomedical ultrasonics have been shifting gradually from 
pure diagnostic imaging toward enhancement of these applications to encompass 
therapeutic uses of ultrasound energy [1-2].  This trend, comprehensively reviewed in [3], 
appears to be associated with the existence of minute air voids that when exposed to 
ultrasound field start to cavitate in a stable or transient mode.  Sonoporation or transient 
membrane permeabilization induced at both low frequency sonication (tens of kilohertz 
frequencies) and diagnostic and therapeutic ultrasound (low megahertz frequencies) 
exposures was discussed as a potential method for localized targeting of well defined 
tissue volume [4].  Several research groups demonstrated that ultrasound exposure could 
make cell membranes temporarily transparent allowing DNA delivery or gene 
transfection [5-10] and could also permeabilize skin for transport of macromolecules [7].  
The results of [7] have shown that low frequency ultrasound (19.6 - 93.4 kHz), with 
intensities (most likely ISATA, spatial average temporal average intensity) between 0.2 
W/cm2 and 2.7 W/cm2, could be used to increase skin permeability.  The outcome 
presented in [11] suggested that ultrasound of 35.1 kHz applied at pressure amplitudes 
between 67.1 kPa and 102.5 kPa could be effective in ultrasonic naked gene delivery 
while maintaining 90% cell viability.  The experimental results published recently by the 
team of the University of Vermont suggested that sonoporation at 2 MHz carried out at 
10% duty cycle and 80 W/cm2, spatial-peak, pulse-average (Isppa) intensity could be 
successful in targeted drug delivery [12].  Several research teams pointed out that 
although bubble cavitation plays a key role in therapeutic applications [13-16], the type 
of cavitation is not always the same.  Whereas in [16] membrane pore formation was 
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conclusively ascribed to transient (violent) cavitation, the results reported in [13] 
demonstrated that acoustic streaming associated with stable (non-violent) cavitation 
could induce liposome rupture.   
Two therapeutic applications of particular interest to the work presented here are 
targeted gene or drug delivery and wound healing; both require modifications of cell 
membrane permeability.  Targeted gene delivery through the use of ultrasound and 
liposomes is an appealing approach because it eliminates the need for viral-mediated 
gene transfer which presents several health concerns, such as cytotoxicity, cytopathy, and 
antigenicity [17].  Ultrasound assisted targeted drug delivery is particularly beneficial for 
treatment of malignant tumors because it reduces the amount of medication necessary for 
a given efficacy, thus alleviating patient discomfort by minimizing the amount of drugs 
delivered to healthy tissue.   
The beneficial effects of ultrasound energy in wound management were 
systematically explored by M. Dyson and her associates [18].  Wound healing, similarly 
to gene and drug delivery, utilizes the interaction between cells and ultrasound energy.  
Although the specific mechanisms of action are still not fully known, the reported data 
are promising.  The results of [19] indicate that ultrasound exposure at 0.75 MHz and 3.0 
MHz at an ISATA of 0.1 W/cm2 could increase vascularization of wounds after five days of 
5 min treatments.   
As noted above, an understanding of ultrasound and cell membrane interaction is 
necessary to optimize applications such as gene or drug delivery and wound healing.  
Research describing the interaction between ultrasound and biological tissue has been 
primarily carried out in two frequency ranges.  The first range employed “conventional” 
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therapeutic ultrasound, entailing frequencies from about 0.5 to 3 MHz [1].  The second 
exposure regime have utilized the frequencies that are one or two orders of magnitude 
lower.  To the best of the authors’ knowledge, there are relatively few papers dealing 
with the ultrasound exposure of biological tissue performed in the frequency range 
between 200 kHz and 500 kHz [20-24].  
In the following, the selected literature data, which are relevant for the discussion 
of the outcome of the work presented here, are briefly reviewed.  The most effective 
liposome-mediated transfection was observed at 1 MHz continuous wave ultrasound 
exposure using ISATA of 0.5 W/cm2 and a fixed ON time of 1 min [17]. An ISATA of 0.5 
W/cm2 ultrasound at 0.75 MHz and 3 MHz was found useful in stimulating the release of 
factors needed for wound healing [25].  Also, it was determined that the 0.75 MHz 
ultrasound was more effective than 3 MHz ultrasound [25].  These results seem to 
suggest that the lower frequency ultrasound exposure could be more effective than the 
one performed in the megahertz range. 
Indeed, there is a sizeable literature that indicates lower frequency (kilohertz) 
ultrasound is linked to non-thermal ultrasound/cell interaction mechanisms and appears to 
be more effective than ultrasound at megahertz frequencies.  It was reported that skin 
pretreated with 20 kHz at an ISAPA of 7 W/cm2 enhanced the transdermal delivery of 
mannitol and inulin [26].  Factors affecting acoustically triggered release of drugs for 
polymeric micelles were examined in [27].  The results indicated that both continuous 
wave and pulsed ultrasound in the frequency range 20 kHz to 90 kHz and unspecified 
power densities on the order of 0.33 to 3 W/cm2 could induce leakage from polymeric 
micelles.   
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There is growing evidence that membrane properties play an important role in 
ultrasound induced changes in cell membrane permeability.  Recently, it was 
demonstrated that leakage and uptake processes could be enhanced by incorporation of 
lipids with a covalently-linked poly(ethylene glycol) moiety (PEGylated lipids) into the 
membrane.  Whether this enhancement resulted from membrane destabilization, 
stabilization of pores, or both is not known at this time [28]. However, regardless of the 
mechanism, these studies revealed that the membrane properties, in general, and its 
composition in particular, can and do influence ultrasound/membrane interactions. Other 
researchers have extended this idea to demonstrate release of fluorescent compounds 
from polymeric micelles [27, 29].   
Relatively few research groups have carried out systematic studies of the 
interaction between ultrasound and cells, e.g. [14, 30].  In general, the literature data 
indicate that it is difficult to utilize animal cells to determine the effect of ultrasound on 
specific membrane properties.  This is because animal cell membranes contain a number 
of variables, such as protein and sterol content, that may alter membrane properties 
significantly.  To overcome this difficulty, the work described in this paper utilized 
phospholipid vesicles as biological membrane models.  Phospholipid vesicles are 
colloidal particles, which are composed of a phospholipid bilayer encapsulating an 
aqueous core.  These structures are similar to cell membranes and are widely accepted as 
biological membrane models [31].  In [31], vesicles composed of either 
phophatidylglycerol/phosphatidylcholine or phosphatidic acid/phosphatidylcholine were 
successfully used to determine the effect of calcium on anionic lipids, which are present 
in all biological membranes.  Furthermore, the vesicles can be readily prepared in the 
 8
laboratory environment; hence the content of the membrane can be altered in a systematic 
and controlled manner.  Although any extrapolation of the in vitro obtained data to living 
tissue calls for caution, the phospholipid vesicles provide a powerful tool in the search for 
optimum acoustic field parameters to be used in targeted drug delivery and wound 
management and the general studies of ultrasound/tissue interaction. 
The main purpose of the research presented here was to identify key parameters 
of ultrasound field on cell membrane permeability using phospholipid vesicles as 
controllable and convenient models.  The effect of frequency, pressure amplitude, 
intensity and rate of delivery was examined using both plane and focused acoustic 
sources.  The membrane properties were modified by changes in vesicle sizes and 
membrane chemistry.  In section 2, the measurement setup together with the acoustic 
sources and relevant exposure parameters is described.  Also, the chemical approach 
allowing vesicle size to be controlled is presented together with a succinct description of 
the fluorescence method used as cell membrane leakage indicator.  In section 3, the 
results are presented.  These include the influence of polyethylene glycol on the 
membrane permeability and the relationship between vesicle curvatures and leakage for 
three size ranges (100 nm, 300 nm, 1 μm) and different ultrasound frequencies (20kHz, 1 
MHz, and 1.6 MHz).  Finally, section 4 contains discussion and conclusions. 
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2. Methods 
This section contains description of the measurement setup together with the acoustic 
sources used.  Also, the relevant exposure parameters are summarized. 
Ultrasound Exposure 
All sonication experiments were performed at room temperature. Three 
ultrasound transducers were used, including a commercial (Misonix Inc., Farmingdale, 
NY, model XL2020) 20 kHz unit with a 3.18 mm (diameter) microtip (Misonix Inc., 
Farmingdale, NY, model 419) and two custom-built sources operating at resonant 
frequencies of 1.0 MHz (diameter = 1.7 cm, unfocused) and 1.6 MHz (diameter = 3 cm, 
focused, with a 3.4 cm focal length).  The custom transducers were fabricated at 
Ultrasound Division, The Institute of Fundamental Technological Research, Polish 
Academy of Sciences, Warsaw.  To facilitate experimental comparison, the diameter of 
the unfocused transducer was chosen to provide the self-focusing distance as close as 
possible to the 3.4 cm.  The self-focusing distance is equal to z = 0.75a2/λ, where z is the 
axial distance from the transducer surface, a is the radius of the transducer, and λ is the 
wavelength [32].  Using this expression, for the 1.0 MHz transducer z was calculated as 
3.6 cm.   
The acoustic field parameters for the three transducers used here are given in 
Table 1.  During the experiments, the 1.0 and 1.6 MHz transducers were positioned in a 
custom-built acoustic chamber filled with degassed, deionized water (Fig. 1).  Vesicle 
solutions were placed into quartz cuvettes (height = 4.5 cm, width = 1 cm).  The opening 
of the cuvette was covered with a thin, 10 μm plastic film (Glad Products Company, 
Oakland, CA).  The cuvette and its contents were lowered into the acoustic chamber, with 
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the plastic film cover facing the surface of the transducer, using a mechanical arm with a 
precision gage.  The purpose of the gage was to enable reproducible positioning of 
samples in the acoustic field and eliminate any effects due to spatial variations.  The 
distance between the surface of the transducer and the plastic film was either 1 mm or 1.5 
cm, depending on the experiment.  These two different distances were needed to position 
focal plane of the 1.6 MHz transducer and the self-focusing plane of the 1 MHz planar 
source approximately in the middle of the cuvette.  
The tip of the 20 kHz Misonix transducer was immersed directly into a 3 mL 
vesicle solution contained in a quartz cuvette.  In the experiments with the custom made 
transducers, the driving signal was generated by a Hewlett Packard 8116A pulse/function 
generator and amplified by an ENI 310L RF power amplifier.  Experiments were 
conducted at 40% duty cycle to minimize the possibility of damaging the sources.  
Additional details of the experiments are given below. 
A PVDF needle (diameter = 0.5 mm) hydrophone probe (Force Institute, 
Denmark), with a 20 dB wideband custom built preamplifier, was used to measure the 
peak pressure amplitudes of the 1.0 and 1.6 MHz transducers.  The hydrophone was 
calibrated in the frequency range 0.25-20 MHz using a TDS approach described in [33-
35].  In the vicinity of 1MHz, the sensitivity of the hydrophone was about 0.255 µV/Pa.  
The setup for the pressure amplitude measurements was similar to that for the ultrasound 
exposure experiment (see Fig. 1).  The needle hydrophone was inserted into a cuvette and 
aligned so its output voltage was maximized.  The pressure amplitude of the megahertz 
sources was determined by measuring the hydrophone output signal displayed on the 
oscilloscope and multiplying it by the sensitivity factor.  No wave distortion was 
 11
observed during these measurements.  The peak rarefractional pressure listed in Table 1 
was calculated as half of the peak-to-peak pressure amplitude.  The experimental data 
presented in the next section were obtained at the pressure amplitudes of 0.47 MPa and 
1.88 MPa for 1 MHz and 1.6 MHz sources, respectively.  Spatial peak temporal average 
intensity was calculated taking into account duty cycle [36-37].  The pressure amplitudes 
generated by the 20 kHz source were measured using two low frequency hydrophones: a 
B&K8103 hydrophone (Brüel & Kjær, Nærum, Denmark) and a TC4038 (Reson Inc., 
Goleta, CA) in a separate water tank.  The B&K8103 hydrophone was calibrated in the 
frequency range 0.1 Hz to 200 kHz and the TC4308 was calibrated from 10 kHz to 1 
MHz.  These hydrophones were also independently calibrated using Time Delay 
Spectrometry technique [33-35].  At 20 kHz, the sensitivity of the B&K hydrophone was 
-211 dB re 1V/μPa, whereas that of TC4038 was -225 dB re 1V/μPa.  The diameter of 
the 20 kHz Misonix device was 3.18 mm so it could be considered as a point source.  
Although physical dimensions of the B&K hydrophone are larger than those of TC4038, 
both hydrophones can be considered as minimally disturbing to the field at 20 kHz.  At 
this frequency, the effective diameters of the B&K8103 and TC4038 were determined to 
be 6.4 mm and 1.6 mm, respectively.  20 kHz frequency corresponds to about 75 mm 
wavelength in water.  Hence, both diameters are much smaller than the wavelength.  The 
point source behavior was verified by performing measurements using both hydrophones 
at three different radial distances, r, namely 6.7 cm, 5.8 cm and 5.2 cm. As expected, the 
hydrophones’ output voltage signals measured at these distances followed 1/r dependence.  
Again, the pressure amplitude was determined as a product of the hydrophone’s output 
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signal and the sensitivity factor.  Spatial peak temporal average intensity was also 
calculated (see Table 1). 
 
Vesicle Peparation 
Small, large, and giant poly(ethylene glycol) (PEG) incorporated 
phosphatidylcholine vesicles with nominal diameters of 100 nm, 300 nm, and 1000 nm 
were used.  The investigation of the possible vesicle size on the membrane properties was 
motivated by referring to the well-known Laplace formula, 2
2
rx
P γ=Δ
Δ , describing the 
pressure gradient, x
P
Δ
Δ , across a spherical interface (where the interface is between 
coexisting gas and liquid phases) [38-39] where γ is interfacial tension, and r is vesicle 
radius.  According to this expression, a ten-fold increase in vesicle radius causes a 
hundred-fold decrease in the pressure gradient needed to cause the bilayer membrane to 
be affected; one would thus expect larger vesicles to leak more readily than the smaller 
ones.   
Small unilamellar vesicles (SUVs) and large unilamellar vesicles (LUVs) were 
prepared by pressure extrusion.  Stock solutions of lipids containing 1,2-Diacyl-sn-
glycero-3 phosphocholine (PC) (Sigma-Aldrich, St. Louis, MO) and 1,2-Dipalmitoyl-sn-
Glycero-3-Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-2000] (PEG2000-
DPPE) (Avanti Polar Lipids, Inc., Alabaster, AL) were prepared in chloroform and dried 
under nitrogen using a rotary evaporator.  The films were re-suspended in a leakage assay 
and vortex mixed. The lipid solution was then passed through two, stacked polycarbonate 
filters (Nuclepore, Whatman Inc., Clifton, NJ) five times in an extruder.  SUVs were 
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prepared using filters with a nominal pore size of 100 nm, and LUVs were prepared using 
filters with a nominal pore size of 400nm.   
Giant vesicles (~1µm) were obtained according to a method described in [40].  
Briefly, stock solutions of lipids were prepared in chloroform and added to 20 mL 
scintillation vials containing 5 mm Pyrex glass beads (Corning, New York, NY).  The 
solvent was then dried in a nitrogen atmosphere for one hour.  After solvent removal, the 
lipid films were rehydrated in the ANTS/DPX buffer described above and incubated in a 
70oC oven for 3 hours.  The ensuing vesicle solution was separated from beads by pipette.  
After vesicles have been obtained using either the extrusion method or the glass bead 
method described here, vesicle solutions were subjected to size exclusion 
chromatography in a Sephadex G50-packed (Sigma-Aldrich, St. Louis, MO) column so 
as to remove any unencapsulated fluorophores.  The column was eluted with a buffer 
solution (pH = 7.4) containing 150 mM NaCl and 5 mM HEPES.   
 
Leakage Measurements 
As mentioned earlier, the dynamics of cell membrane permeation is considered to 
be a crucial parameter in gaining some insight into ultrasound/cell membrane interaction 
and plays an important role in gene and drug delivery applications.  It is also likely that 
changes in membrane permeability have an influence on wound healing processes [25].  
To evaluate the changes in membrane permeation and mimic drug release from cells, a 
leakage assay, developed by [41], was used.   The leakage buffer contained 60 mM NaCl, 
5 mM CaCl2, 5 mM HEPES, 3 mM NaN3 (Sigma-Aldrich, St. Louis, MO), 12.5 mM 1-
aminonaphthalene-3,6,8-trisulfonic acid, disodium salt (ANTS), and 45 mM N,N’-p-
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xylylenebis(pyridinium bromide) (DPX) (Molecular Probes, Invitrogen, Eugene, OR) and 
was equilibrated to a pH of 7.4.  When encapsulated within the aqueous vesicle core DPX 
quenched ANTS fluorescence by collisional transfer due to the proximity of the 
molecules [41].  Once the leakage occurred, ANTS and DPX were released from the core, 
thereby increasing the distance between an ANTS and a DPX molecule.  The result was 
an increase in measured fluorescence, indicating enhanced leakage which in turn was 
indicative of increased permeation. 
In the experiments described in the following, the fluorescence measurements 
were carried out with a Photon Technology International, Inc. (Birmingham, NJ), A-710 
steady-state fluorescence spectrometer.  The 355 nm wavelength of the excitation signal 
applied to ANTS solution aided the ANTS molecule to be transferred to an excited state.  
Upon returning to the equilibrium state, ANTS molecules release the energy at 500 nm 
wavelength.   To ensure that the emission intensity of ANTS was recorded correctly, the 
spectra corresponding to 450 nm and 550 nm were also measured.  Fig. 2 shows the 
characteristic fluorescence emission spectra obtained from an LUV sample at different 
sonication times using a 1 MHz unfocused transducer.  These initial experiments revealed 
an increase in the measured fluorescence intensity with increased sonication time.  
Although the maximum intensity did not always occur at precisely the same wavelength 
it was apparent that the nominal wavelength giving maximal intensity was approximately 
500 nm.   A wavelength of 500 nm was therefore selected for the purpose of quantifying 
leakage in all experiments.   
Leakage was assessed as a percentage of complete release.  The complete release 
was defined by dissolution of the vesicles using Triton X-100 (Sigma-Aldrich, St. Louis, 
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MO).  Triton X-100 is a surfactant which, owing to its small hydrophobic tail, can 
partition readily in and out of lipid membranes which causes a destabilization of the 
membrane [28].  At concentrations greater than 0.3 mole%, Triton X-100 has been found 
to cause catastrophic solubilization of the membrane [28].   Fractional release was 
calculated using the following equation (3): Fractional Release (%) %100×−
−=
iniTX
iniobs
FF
FF
, 
where Fobs was the observed fluorescence intensity, Fini was the initial intensity (0% 
leakage), and FTX (100% leakage) was the final intensity after Triton X-100 addition.  In 
the present studies ultrasound was applied outside the fluorescence spectrometer, and 
ultrasound exposure was interrupted to perform fluorescence scans.  All fluorescence 
measurements were taken after carefully chosen ON/OFF time intervals, where the OFF 
interval was fixed at 5 minutes, and the ON was either fixed at 10 minutes or allowed to 
vary as described in the following.  The selection of 10 min sonication time was based on 
preliminary experiments (results not shown here) in which different sonication time 
intervals were tested to determine which of them yielded the best tradeoff between 
physical agitation or mixing and cavitation effects.  In selected experiments, as described 
below, the ON interval was allowed to vary to determine the effect of varying exposure 
times on the leakage.  A summation of all ON times yielded the total exposure time.  For 
example, twenty-four ON intervals of 10 minutes corresponded to a total exposure time 
of 4 hours or 240 minutes.  OFF time refers to the intermission between ON exposures.  
Five minutes were needed to remove the cuvette from the sonication setup (Fig. 1) and 
perform a fluorescence measurement to assess the leakage.  Hence, the OFF time interval 
was fixed at 5 minutes for all samples irrespective of the ON interval.  
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With increasing sonication time, the number of condensation and compression 
phases undergone by gas nuclei increased as well.  Accordingly, the likelihood for onset 
of stable or inertial cavitation should have also increased.  Therefore, a longer ON time 
interval would appear to be desirable to obtain higher leakage.  However, there was 
another aspect that needed to be taken into consideration when selecting the ON time 
interval.  It is well known that physical agitation enhances the effect of cavitation by 
increasing the distribution of cavitating nuclei to cells or vesicles [42-43].   During the 
experiments described here, no mixing was possible during sonication.  Physical agitation 
occurred when the cuvette, containing the vesicle solution, was removed from the cuvette 
holder and inverted twice.  Hence, when comparing two samples both with total exposure 
times of 4 hours, a sample with ON cycles of 10 minutes would have received more 
agitation than a sample with ON time of 15 minutes because the 10 minute sample would 
have been exposed to 24 OFF cycles in which physical agitation occurred while the 15 
minute sample would have only experienced 16 cycles.      
In addition to the steady-state fluorescence spectrometer, samples of giant 
vesicles (GVs) were examined after preparation to ensure encapsulation of dyes using a 
Zeiss Axioskop2 fluorescent microscope equipped with a Zeiss Axiocam with an 
Axiovision V2.05 ultraviolet digital imaging system.  Aliquots of 10 µL were mounted 
on a slide and first examined in the light field (Fig. 3a), then dimmed by insertion of a 
fluorescence filter (Fig. 3b).  The results of Fig. 3 show that encapsulation of ANTS may 
be verified by the presence of fluorescence in the vesicle as observed under a fluorescent 
microscope.  As noted before, ideally ANTS and DPX should not fluoresce if they are in 
proximity of each other.  However, in practice this rarely happens.  As shown in Fig. 3, 
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the complete quenching effect did not occur in experiments and resulted in some degree 
of fluorescence in the vesicles.   
Vesicle sizes were measured using a Brookhaven 90Plus dynamic light scattering 
apparatus.  This system consisted of a 15 mW, solid-state laser operating at a 678 nm 
wavelength and a BI-9000AT digital autocorrelator.  The measured autocorrelation 
functions were analyzed for the first and second cumulants of a cumulant fit, which 
provided measures of the apparent diffusivity and polydispersity, respectively.  The data 
were given in terms of an effective diameter using the Stokes-Einstein equation: 
Effective diameter 
D
TkB
πν3= , where kB is the Boltzmann constant, T is the temperature 
(25oC), ν is the solvent viscosity, and D is the diffusivity from the first cumulant. 
Dynamic light scattering data indicated the size of the SUVs to be approximately 100 nm, 
LUVs size was 300 nm, and GVs had a polydisperse population with a mean diameter of 
approximately 1µm.  It should be noted that while dynamic light scattering software 
measured the size of the GVs to be 1µm, the software also indicated that there were 
vesicles smaller than 100 nm present in the sample.  Additionally, vesicles as large as 20 
µm have also been seen under a light microscope.  Hence, it would be more appropriate 
to say that the sample of GVs, as analyzed by dynamic light scattering, exhibited sizes 
ranging from 100 nm to 20 µm and that the measured, effective diameter was 
approximately 1 µm.
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3. Results 
Initial experiments were performed to determine the amount of poly(ethylene 
glycol) (PEG) to be incorporated into the vesicle membrane.  Fig. 4 shows the release 
profiles from SUVs (~100 nm - effective diameter as measured by dynamic light 
scattering) composed of 0 mol% PEG, 2 mol% PEG, 5 mol% PEG, and 8 mol% PEG 
using a 20 kHz immersion probe transducer.  It can be seen that PEG enhanced 
ultrasound-induced leakage in a dose-dependent fashion until approximately 5 mol%.  
Beyond this PEG concentration, no further enhancement was observed (the 5 mol% and 8 
mol% samples showed approximately the same leakage profile).  It is appropriate to note 
that at this frequency nearly 100% leakage was achieved in ten minutes.  
It is conceivable that due to a large head group, PEGylated lipids may partition 
preferentially so as to eliminate hydrocarbon exposure to water and thereby stabilizing 
pores.  To test the hypothesis that PEG forms “permanent” pores in the membrane, small 
unilamellar vesicle (SUV) samples containing 5 mol% PEG were sonicated for 30 
seconds using the 20 kHz Misonix sonicator and observed for any changes in 
fluorescence intensity.  Fig. 5 shows the leakage profile of four samples after cessation of 
ultrasound.  Each sample had different ultrasound-induced leakage.  No additional 
leakage was observed up to 240 min after termination of ultrasound. 
After examination of the effect of PEG, the relationship between vesicle curvature 
and ultrasound susceptibility was investigated using vesicles of three size ranges:  100 
nm, 300 nm, and 1 µm.  Fig. 6 shows the average leakage profile of these vesicles using a 
1.0 MHz unfocused transducer.  The distance between surface of transducer and plastic 
film on cuvette was 1 mm.  In each graph, error bars correspond to standard deviation and 
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were based on the results obtained from four samples.  For each vesicle size, two aliquots 
of the sample were prepared; one served as a control and was not exposed to ultrasound, 
a second served as a test sample and was exposed to ultrasound.  All control samples, 
irrespective of vesicle size, showed no evidence of leakage.  Ultrasound was applied at 
constant ON time intervals of 10 minutes and OFF intervals of 5 min.  As noted before, a 
5 min OFF interval was necessary for removal of cuvette from set-up and to complete a 
fluorescence reading.  The effect of vesicle size for the same total exposure time of 240 
minutes is summarized in Fig. 6.  SUVs (diameter ≈ 100 nm, Fig. 6a) showed no 
evidence of leakage.  LUVs (Fig. 6b) with average diameters of approximately 300 nm 
resulted in leakage approaching 32%. GVs (Fig. 6c) with average diameters of 1 µm 
yielded the greatest leakage level, nearly 47%. 
Further examination of multiple GV samples, each with a different effective 
diameter, as calculated by dynamic light scattering software, confirmed the dependence 
of leakage on vesicle size (Fig. 7).  After four hours, the GV sample with the smallest 
average diameter (~836 nm) yielded 28% leakage, the intermediate (~888 nm diameter) 
sample resulted in 40% leakage, and the sample with the largest average diameter (~947 
nm) exhibited 57% leakage.   
To further examine the influence of frequency and the possible role of cavitation 
on the amount of leakage observed from giant vesicles, samples with diameters in the 
range 836-947 nm were again insonified with 1.0 and 1.6 MHz sources.  The likelihood 
of cavitation is often estimated using mechanical index, defined as [44-45], 
f
P
MI neg= , 
where Pneg is the peak rarefactional or negative pressure amplitude (Table 1) and f is the 
center frequency of the transducer.  Increasing the negative pressure or decreasing the 
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frequency increases the mechanical index and hence the likelihood of cavitation.  To 
examine the effect of peak rarefactional pressure, a 1.6 MHz focused transducer and giant 
vesicles were selected.  The 4.5 cm in height cuvette, see Fig. 1, containing the giant 
vesicle sample was placed using the precision gage so that the distance between the 
plastic film and the surface of the transducer was 1.5 cm.  The reason for this 1.5 cm 
distance, as compared to the 1 mm distance used in the previously mentioned 
experiments, was to allow the focal region to be located at approximately middle of the 
sample.  Thus, the height within this cuvette taken up by the sample was 3 cm.  For 
comparison, these experiments were repeated using the unfocused 1 MHz transducer with 
a self-focusing region at 3.6 cm.  Fig. 8a shows the resulting leakage profile of both the 
1.0 MHz and 1.6 MHz transducer.  The 1.0 MHz and 1.6 MHz data shown in Fig 8a. are 
each the average of four samples;  for clarity, the error bars were omitted.  Each 
individual set of data is graphed in Fig. 8b, for the 1.0 MHz transducer, and Fig. 8c, for 
the 1.6 MHz transducer, with the corresponding error bars.  The results of Fig. 8 indicate 
that the unfocused transducer induced slightly more leakage than the focused one.  
However, it should be noted that the results of Fig 8a. were conducted a year after those 
presented in Fig. 6.  Hence the lipids from the two sets of experiments were from 
different batches.  It is most likely that lipids from two different batches have contained 
different amounts of saturated and unsaturated lipids which could ultimately cause 
variations in the “leakiness” of the vesicles.  This issue is further discussed in the next 
section.  
With respect to ON/OFF time intervals for ultrasound exposure, an unanticipated 
but repeatable trend was observed and is depicted in Fig. 9.  The purpose of this 
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experiment was to examine the effect of sonication time on leakage.  Again, the 
ultrasound of 1.0 MHz was applied to the giant vesicles and the distance between the 
plastic film and the transducer was 1 mm. The OFF time was kept at 5 minutes; as noted 
earlier this was the minimum time needed for fluorescence measurements.  An initial ON 
interval of 5 min was selected.  This ON interval was maintained as long as the leakage 
level was increasing.  When leakage appeared to be leveling off, observed as close to no 
change in fluorescence intensity, the ON interval was increased.  The ON intervals were 
chosen in the following way: 10 min intervals from 30 min to 60 min, 30 min intervals 
from 60 min to 120 min, 60 min intervals from 120 min to 240 min and 3 hours of 
continuous sonication from 240 min to 420 min.   A steep increase in leakage was noticed 
between 120 min and 180 min for each test sample.  The possible reasons for these 
results are discussed in the next section. 
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4. Discussion 
Liposomes containing poly(ethylene glycol) (PEG) have been studied extensively 
as drug delivery vehicles due to their increased stability in the blood stream as compared 
to liposomes without PEG [46].  Cancer drugs such as doxorubicin and vincristine have 
already been encapsulated within polymeric micelles [27, 47].   Recent studies have also 
indicated that PEGylated liposomes are more “susceptible” to ultrasound [28].  However, 
there is a limit with respect to the amount of PEG that can be incorporated into a vesicle.  
The results described in [28] have shown that at PEG (1,2-Dipalmitoyl-sn-Glycero-3-
Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-2000]) concentrations greater 
than 8 mol%, the membrane becomes saturated with PEG-lipids and any remaining PEG-
lipids will form micelles.  The initial results presented in Fig. 4 appear to confirm the 
conclusions of [28] and show that incorporation of PEG into the investigated model 
membranes enhanced leakage up to a concentration of 5 mol%.  Since a PEG 
concentration of 8 mol% did not enhance leakage further than a composition of 5 mol%, 
the latter concentration was selected here to avoid the possible saturation effect.   
Based on PEG’s ability to cause perturbations within the membrane, it was 
hypothesized that PEG moieties in the membrane could stabilize an ultrasound-induced 
pore within the vesicle bilayer, preventing its re-sealing.  The results of Fig. 5, however, 
suggested that this was not the case.  Four samples of small unilamellar vesicles (SUVs) 
with different initial leakage, as induced by the 20 kHz Misonix sonicator, showed no 
leakage after 4 hours of monitoring.  The lack of a further increase in leakage upon 
cessation of ultrasound indicated there were no PEG-stabilized “permanent” pores.  This 
result is consistent with the findings of [4].  Nevertheless, PEGylated lipids provide an 
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enhancing effect with respect to leakage so that one can envision tailoring vesicles of 
various compositions to achieve specific leakage rates.  Such approach could be 
applicable in cancer medication delivery. 
 In addition to chemical membrane composition, the results of the experiments 
described above indicate that the geometry of the vesicles, specifically their curvature 
plays a role in influencing the permeability of a membrane.  When the physical 
dimensions of the vesicle are small in comparison to the acoustic wavelength, the vesicle 
is exposed to a virtually uniform pressure, and the associated pressure gradient can be 
considered to be negligibly small.  Hence, there is no net shear force acting on the vesicle.  
However, when the dimensions of the vesicle become comparable to the wavelength, the 
pressure is no longer uniform and produces an associated shear force, which acts on the 
vesicle surface.  It is conceivable that this force might lead to the rupture of the bilayer 
membrane.  Experiments are underway to explore this possibility more closely.  At 1 
MHz, the wavelength in water is approximately 1.5 mm, which is about four orders of 
magnitude greater than the diameter (100 nm) of a small unilamellar vesicle (SUV).  
Accordingly, it could be expected that the ultrasound exposure at 1 MHz would induce 
negligible or no leakage in SUVs, however, it should have an effect on vesicles of larger 
diameters.  Moreover, phospholipid bilayers have zero spontaneous curvature so that an 
increase in vesicle size, with a concomitant decrease in vesicle curvature, necessarily 
decreases both the free energy per unit area and the bending rigidity, or bending elastic 
modulus, of the vesicle bilayer.  Giant vesicles would thus have less resistance toward 
withstanding shear stresses than small unilamellar vesicles or large unilamellar vesicles.  
This notion is supported by the data shown in Figs. 6 and 7.  Fig. 6 depicts the results in 
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terms of fractional release of small unilamellar vesicles (100 nm), large unilamellar 
vesicles (300 nm), and giant vesicles (1 µm) exposed to 1 MHz ultrasound at the 3.0 
W/cm2 intensity (spatial peak temporal average).  The results of Fig. 6 indicate that an 
increase in the vesicle’s size, with concurrent decrease of its curvature, led to an 
enhanced leakage rate.  It should be noted that the method used for giant vesicle 
preparation (see Methods section) has not yielded a monodispersed population with the 
same average diameter every time.  Consequently, the variation in leakage rates in the 
giant vesicle samples could be expected to be higher than that observed for the vesicles 
prepared by the extrusion method, namely small unilamellar vesicles (SUVs) and large 
unilamellar vesicles (LUVs).  The results shown in Fig. 7 further support the above 
discussed wavelength dependency; the largest vesicle (947 nm dia.) yielded the highest 
fractional release or leakage. 
This size-dependent effect can also be traced to a pressure gradient across the 
vesicle bilayer, which scales with the inverse second power of vesicle radius, r, in 
accordance with the Laplace equation (See Methods section).  Accordingly, the pressure 
required to shear a hole in a vesicle bilayer has to increase sharply (proportional to 1/r2) 
as the vesicle radius decreases.  As noted in Table 1, the peak-to-peak pressure generated 
by the 20 kHz source was 0.06 MPa whereas that of the 1 MHz source was 0.47 MPa.  
This suggests that the pressure amplitude generated by the 20 kHz source that was 
causing leakage from the small unilamellar vesicles was not the only reason for increased 
fluorescence.  In a medium containing microbubbles, sonication can cause these bubbles 
to grow due to the rectified diffusion phenomenon [45, 48].  The bubbles eventually grow 
to their resonance size and eventually implode (transient caviation) or continue to vibrate 
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without breaking up (stable cavitation).  Stable cavitation often leads to acoustic 
streaming, i.e. time-independent flow generated by sonication in the presence of 
microbubbles [49-50].  This phenomenon can lead to local increase in shear stresses and 
may result in membrane damage.  Transient cavitation can generate local pressures on the 
order of 100 MPa and as the cavitation threshold decreases with decreasing ultrasound 
frequency, it is conceivable that the 20 kHz ultrasound exposure produced cavitation 
amplified pressure amplitudes that exceeded the Laplace pressure even for the smallest 
diameter vesicles (here: 100 nm) and induced leakage.   
Based on the results presented here, it is likely that both stable and transient 
cavitation contributed to the enhanced fluorescence level.  In the experiments underway, 
the presence of transient cavitation will be monitored.  Should the presence of transient 
cavitation be verified, it would confirm that in addition to the curvature and chemical 
composition the dynamic permeability of the membrane is influenced by the ultrasound 
frequency.   
Ultrasound of 20 kHz is commonly used to prepare small, unilamellar vesicles 
from large, multi-lamellar vesicles [51].  This process is highly destructive to the 
membrane, resulting in membrane fragments being displaced from the parent membrane 
and complete leakage of vesicle contents.  The results of Fig. 6 suggested that the leakage 
induced by 1 MHz ultrasound was not highly destructive; the leakage from LUVs and 
GVs reached an equilibrium level whereas SUVs subjected to 20 kHz ultrasound (Fig. 4) 
reached 100% leakage within ten minutes. This outcome indicates that 1 MHz ultrasound 
may be used to nondestructively leak poly(ethylene glycol) incorporated vesicles, and 
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may prove to be an attractive candidate for drug and gene delivery in which cell lysis is 
undesirable.    
In addition to the frequency and physico-chemical properties of the sample, the 
role of focusing on the interaction between ultrasound and bilayer membranes was also 
examined.  As noted previously, the focal region of the 1.6 MHz transducer had a peak 
rarefactional pressure amplitude of 0.94 MPa whereas the pressure generated by the 1.0 
MHz transducer was 0.24 MPa (see Table 1).  According to the formula defining the 
mechanical index (MI, see previous section), the higher peak rarefactional pressure will 
result in higher MI and thus a higher likelihood of cavitation.  However, whereas the 
pressure of 0.94 MPa is volumetrically limited, the pressure produced by the field of the 
1.0 MHz transducer, even at the self-focusing region, is more dispersed and affects a 
larger cross sectional area than that generated by the 1.6 MHz focused transducer.  The 
results of Fig. 8 show that the 1.0 MHz transducer was actually able to induce slightly 
more leakage (~10%) than the 1.6 MHz one (~5%).Hence, the focusing is only somewhat 
effective in increasing membrane’s permeability.    
It should be recalled that the experimental results shown in Fig. 8 and the results 
presented in Figs. 4, 6, 7, and 9 were performed using two different batches of lipids.  As 
the preparation of lipids involved the use of phosphatidylcholine from eggs, the type of 
lipids, namely the amount of saturated and unsaturated lipids, in each batch varied 
because different eggs were used.  Unsaturated lipids have cis double bonds that interfere 
with its packing in the membrane [52].  At a given temperature, as the number of 
unsaturated lipids increase, the stability of the system decreases.  Hence, the leakage level 
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of Fig. 8 differs greatly from the leakage level shown in Fig. 6c.  Additional experiments 
are underway in which single lipid systems will be used in preparation of the vesicles. 
Another interesting finding of this study was the time-dependent phenomenon 
revealed by the data presented in Fig. 9.  Whereas continuous leakage profiles were 
observed in Figs. 6-8, wherein a fixed ultrasound ON interval of 10 minutes was used, a 
time discontinuity was observed when the duration of ultrasound ON intervals was varied.  
In particular, the extent of leakage seemingly reached a plateau of approximately 20% 
after two hours of sonication, followed by what appeared to be a secondary leakage at 
three hours and eventually settled at a second plateau at approximately 60%.  There are at 
least two possible explanations for this behavior.  First is that these samples might have 
contained bi-modal populations of vesicles.  Given that different vesicle diameters 
produced different leakage profiles (Fig. 6) the results of Fig. 9 might simply be due to 
the existence of multiple vesicle populations, perhaps inherent in the method of giant 
vesicle synthesis.   
A second possibility relates directly to the ON time for ultrasound exposure.  As 
no external gas bubbles were added in these experiments, nucleation and growth of 
bubbles to their resonance size must have occurred.  Therefore, it is likely that the three 
10-minute ultrasound ON intervals, with an OFF interval between each to allow for 
fluorescence scans, were not fully equivalent to a single, 30-minute ultrasound ON 
exposure.  Consistent with this notion is the qualitative observation that during 10 min of 
1 MHz exposure, no gas bubbles were visible to the naked eye in the sample.  Gas 
bubbles became clearly visible only after 30 minutes of continuous sonication, and the 
number of bubbles increased with exposure times longer than 30 minutes.  This result 
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indicate that the ON/OFF time constitutes an important parameter of the exposure field.  
Long (here 20 min) ON times facilitate nucleation and growth of (cavitating) bubbles, 
whereas, short (here 10 min) ON time intervals allow redistribution of bubbles and 
vesicles by sample inversion and are not sufficiently long to allow growth due to the 
rectified diffusion [48].  To gain further insight into these effects, a design of an acoustic 
chamber with constant mixing and real-time fluorescence measurement capabilities is 
planned.   
In conclusion, the results of the experiments aimed at comparing the effects of 
ultrasound at two frequency ranges, low (kilohertz) range and conventional therapeutic 
(0.5-3 MHz) one, on model membranes having diameters of 100 nm, 300 nm, and 1 μm, 
and PEG concentrations, 0 mol%, 2 mol%, 5 mol%, and 8 mol% were presented.  Simple 
vesicle models were employed and proved to be useful as a convenient tool to mimic 
membrane behavior in vitro in a controllable manner.  The results indicated that the 
leakage from vesicles could be enhanced by a) increasing the poly(ethylene glycol) 
concentration to 5 mol%, b) decreasing membrane curvature by increasing vesicle 
diameter, c) increasing the likelihood of transient cavitation by decreasing the frequency 
generated by the ultrasound source and d) controlling the ON time.   
This study demonstrated that ultrasound-induced leakage across a phospholipid 
bilayer is feasible at both conventional (low MHz range) therapeutic frequencies and at 
much lower (20 kHz range) frequencies.  Furthermore, the 20 kHz ultrasound exposure 
generated more leakage than that observed at 1 and 1.6 MHz.  A highlight of the present 
study was the finding that the rate and extent of leakage varied significantly with vesicle 
curvature, with the susceptibility to leakage increasing with vesicle diameter.  This effect 
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was attributed to a Laplace-like pressure gradient across the vesicle bilayer.  The Laplace 
equation describes excess pressure within a gas bubble surrounded by a liquid phase; that 
pressure is proportional to twice the interfacial tension (at the gas/liquid interface, which 
is presumed spherical) and is inversely proportional to bubble radius.  A similar equation 
holds for a soap bubble (that is, a gas bubble – coated with a liquid shell – surrounded by 
a gas); excess pressure in this case is proportional to four times the interfacial tension, but 
the inverse distance dependence still holds.  It is therefore reasonable to anticipate that 
the excess pressure will diminish with increasing vesicle radius, if not linearly.  The 
results presented also appeared to underscore the role that membrane properties play in 
the interaction with ultrasound and suggested that membrane composition and curvature 
might serve as tuning parameters to achieve specific and controllable leakage rates in 
therapeutic applications.  One of the ultimate goals of this research is to create a targeted 
drug delivery system that would enable physicians to optimize the conditions for drug 
release.  The results of this work contribute to a better understanding of the interaction 
between ultrasound and phospholipid membranes and will help to improve the control 
over the delivery vehicles, liposomes, and the receivers, cells.  Hence, the results 
presented here can be considered as a stepping stone to achieve this goal. 
 The experiments presented here also indicated the importance of acoustic 
exposure parameters including transducer geometry, duty cycle, frequency, and pressure 
amplitude.  Further experiments need to be completed to determine whether there exists a 
single factor, such as energy density, that governs the effect ultrasound has on cell 
membranes.   
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Building on the general idea that membrane properties are also important with 
respect to the interaction between phospholipids bilayers and ultrasound, the influence of 
cholesterol deserves consideration.   Cholesterol exhibits a well-known “condensing” 
effect on phospholipid membranes [53-54] and decreases passive diffusion rates and rates 
of leakage mediated by stimuli other than ultrasound [55].  Moreover, within certain 
cholesterol composition ranges, multiple phases (liquid-ordered and liquid-disordered) 
coexist in the membrane [56-57].  Such multiple phases also exist in cell membranes, 
giving rise to cholesterol-rich domains termed “lipid rafts” [47, 58].  The interfacial 
tensions of these multiple phases are likely to be different, and the results of this study 
would therefore suggest that ultrasound-induced leakage occurs either preferentially 
within cholesterol-rich regions of the bilayer or on the border of these regions.  Studies 
are underway to test this hypothesis. 
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Figure and Legends 
Table 1: Key exposure parameters and pressure amplitudes used in this work. Exposure 
time details are given in the text. 
 
Figure 1:  Ultrasound chamber design for steady state fluorescence measurements.  An 
inverted cuvette was held above the ultrasound chamber during exposure time.  The 
distance between the radiating surface of the acoustic source and the plastic film, which 
separates vesicle contents in the cuvette from the acoustic water bath, was 1 mm and 15 
mm from the surface of the transducer, depending on the experiment.   a) Schematic of 
exposure chamber, b) Photograph of exposure chamber.  See text for details.   
 
Figure 2: Fluorescence intensity change in a large unilamellar vesicle (LUV) sample 
after application of ultrasound.  A 1 MHz unfocused ultrasound transducer set at 40 % 
duty cycle was used and generated a peak-to-peak pressure amplitude of 0.47 MPa.  
Increase in fluorescence intensity was due to ANTS leakage from the vesicle core.  See 
text for details. 
 
Figure 3:  Optical microscopy pictures of giant vesicle (GV).  The vesicle was prepared 
using the glass bead method described in [28]. Vesicle was observed under normal light 
and under a fluorescence lamp.  a) Maximum size of the GVs used in this work, as 
observed under light microscope, was 20 μm.  b)  The same vesicle observed after 
insertion of a fluorescence filter.  
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Figure 4: Fractional release rate as a function of PEG concentration.  A 20 kHz source 
was immersed in a 3 mL sample of vesicles.  At specified time intervals, ultrasound was 
stopped and a fluorescence reading of the sample was taken.  100 mol% release was 
based on the fluorescence measurements observed after the addition of triton X-100.  
Data shown are of SUVs composed of 0 mol% PEG (♦), 2 mol% PEG (■), 5 mol% PEG 
(▲), and 8 mol% PEG (●).  See text for details. 
 
Figure 5:  Lack of permanent pores at 20 kHz exposure. Ultrasound from the 20 kHz 
Misonix device was applied to four SUV samples.  (♦, ×, ▲, -).  The leakage after 
termination of ultrasound was monitored to determine the existence of permanent pores.  
Fluorescence measurements indicated that no leakage occurred after sonication was 
terminated.  100% release was based on the intensity observed after addition of triton X-
100.  A control sample (■) was also monitored. 
 
Figure 6: Average fractional release of SUVs, LUVs, and GVs. A 3 mL vesicle sample 
(♦) was subjected to ultrasound of 40% duty cycle and peak-to-peak pressure of 0.47 
MPa using an unfocused 1 MHz transducer while another vesicle sample was used as a 
control (■).  100% release was determined based on the intensity observed after addition 
of triton X-100.  Each data point is based on the average of four samples.  Error bars 
correspond to standard deviation of four samples.  a) Average leakage from SUVs.  b) 
Average leakage from LUVs.  c) Average leakage from GVs.   
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Figure 7: Release rate variance as a function of GV size.  Samples of GVs were 
subjected to ultrasound of 40% duty cycle and peak-to-peak pressure of 0.47 MPa from 
an unfocused 1MHz transducer.  At 10 min intervals, ultrasound was turned off and a 
fluorescence reading was taken.  The OFF interval was approximately 5 minutes. 100% 
release was determined based on the intensity observed after the addition of triton X-100.  
The samples shown here were 836 nm (●), 888 nm (▲), and 947 nm (■). 
 
Figure 8: Focused and unfocused ultrasound exposure of GVs.  Release profile of GVs 
using a focused 1.6 MHz transducer and an unfocused 1 MHz transducer.  Cuvettes for 
this set of experiments were placed so that the focal region of the transducers was located 
in the middle of the sample.  See section Methods for details.  a) Leakage profiles from 
GVs using a (♦) 1 MHz transducer, a (▲) 1.6 MHz transducer, and (■) no sonication.  
Each profile is based on the average of four samples.  Error bars were omitted for clarity.  
The individual profiles are graphed in b) for the 1 MHz transducer and c) for the 1.6 MHz 
transducer with corresponding error bars representing standard deviation from four 
samples.  In both graphs (b) and (c) ♦ represent the sonicated samples and ■ represents a 
control sample with no sonication.  100 % release was determined based on the intensity 
observed after the addition of triton X-100.   
 
Figure 9:  Effect of sonication time on leakage.  GV samples were subjected to 
ultrasound of 40 % duty cycle and peak pressure of 0.47 MPa from an unfocused 1MHz 
transducer.  At selected intervals, ultrasound was turned off and a fluorescence reading 
was taken of two sonicated samples, sample 1 (♦), sample 2 (▲), and a control sample 
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(■).  The sonication time was as follows:  5 min intervals from 0-30 min, 10 min intervals 
from 30-60 min, 30 min intervals from 60-120 min, 60 min intervals from 120- 240 min, 
and 3 hr continuous sonication from 240 min to 420 min.  The OFF interval was 
approximately 5 minutes. The maximum leakage obtained was 62% with a significant 
increase in leakage level between 120 min to 180 min.  
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Figures and Table 
 
Center 
Frequency 
Duty 
Cycle 
Peak-to-Peak 
Pressure 
(MPa) 
Peak 
Rarefractional 
Pressure 
(MPa) 
Ispta 
(W/cm2) 
20 kHz 100% 0.06 0.03 0.13 
1.0 MHz 40% 0.47 0.24 3.00 
1.6 MHz 40% 1.88 0.94 46.90 
 
Table 1 
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